Spheroplast-Mediated Carbapenem Tolerance in Gram-Negative Pathogens.

Amdinocillin / pharmacology Anti-Bacterial Agents / pharmacology Drug Tolerance Enterobacter aerogenes / drug effects Enterobacter cloacae / drug effects Escherichia coli / drug effects Gram-Negative Bacterial Infections / drug therapy Klebsiella pneumoniae / drug effects Meropenem / pharmacology Microbial Sensitivity Tests Spheroplasts / drug effects
L-form antibiotic carbapenem carbapenemase meropenem tolerance

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
09 2019
Historique:
received: 08 04 2019
accepted: 28 06 2019
pubmed: 10 7 2019
medline: 4 7 2020
entrez: 10 7 2019
Statut: epublish

Résumé

Antibiotic tolerance, the ability to temporarily sustain viability in the presence of bactericidal antibiotics, constitutes an understudied and yet potentially widespread cause of antibiotic treatment failure. We have previously shown that the Gram-negative pathogen

Identifiants

DOI: 10.1128/AAC.00756-19 PMID: 31285232 PMC: PMC6709500
pubmed: 31285232
pii: AAC.00756-19
doi: 10.1128/AAC.00756-19
pmc: PMC6709500
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Meropenem FV9J3JU8B1
Amdinocillin V10579P3QZ

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI143704
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM113172
Pays : United States

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

Biochem Soc Trans. 2017 Apr 15;45(2):287-295
pubmed: 28408469
Protein Sci. 2011 Sep;20(9):1484-91
pubmed: 21774017
Annu Rev Microbiol. 2010;64:357-72
pubmed: 20528688
J Pharm Anal. 2016 Apr;6(2):71-79
pubmed: 29403965
Nat Rev Microbiol. 2016 Apr;14(5):320-30
pubmed: 27080241
Biophys J. 2017 Jun 20;112(12):2664-2671
pubmed: 28636922
Angew Chem Int Ed Engl. 2012 Dec 7;51(50):12519-23
pubmed: 23055266
Science. 2017 Feb 24;355(6327):826-830
pubmed: 28183996
BMC Microbiol. 2006 Jun 12;6:53
pubmed: 16768798
BMC Bioinformatics. 2017 Nov 29;18(1):529
pubmed: 29187165
Cell. 2007 Sep 7;130(5):797-810
pubmed: 17803904
Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):404-9
pubmed: 26712007
PLoS Pathog. 2015 May 22;11(5):e1004933
pubmed: 26000450
ISME J. 2019 May;13(5):1239-1251
pubmed: 30647458
Philos Trans R Soc Lond B Biol Sci. 2016 Nov 5;371(1707):
pubmed: 27672147
Science. 2004 Sep 10;305(5690):1622-5
pubmed: 15308767
Antimicrob Agents Chemother. 2015 Mar;59(3):1707-17
pubmed: 25583711
Br Med J (Clin Res Ed). 1984 Nov 24;289(6456):1409-12
pubmed: 6437576
Nat Chem Biol. 2016 Jul;12(7):516-22
pubmed: 27182662
Nature. 2018 Jul;559(7715):617-621
pubmed: 30022160
Cell. 2014 Dec 4;159(6):1300-11
pubmed: 25480295
Nat Rev Microbiol. 2007 Jan;5(1):48-56
pubmed: 17143318
J Chemother. 2013 Feb;25(1):1-17
pubmed: 23433439
Drugs. 2008;68(6):803-38
pubmed: 18416587
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Clin Infect Dis. 2018 Apr 3;66(8):1290-1297
pubmed: 29165604
Clin Microbiol Rev. 2015 Jan;28(1):191-207
pubmed: 25567227
Rev Infect Dis. 1979 May-Jun;1(3):434-67
pubmed: 45147
J Pediatr. 1995 May;126(5 Pt 1):799-806
pubmed: 7752010
Sci Rep. 2017 Feb 01;7:41284
pubmed: 28145464
J Antimicrob Chemother. 1995 Jul;36(1):53-64
pubmed: 8537284
Pediatr Infect Dis J. 2004 May;23(5):399-405
pubmed: 15131461
PLoS Pathog. 2015 Apr 17;11(4):e1004850
pubmed: 25884840
Science. 2004 Sep 10;305(5690):1629-31
pubmed: 15308764
J Antimicrob Chemother. 2015 Feb;70(2):382-95
pubmed: 25266070
Antimicrob Agents Chemother. 2018 Sep 24;62(10):
pubmed: 30061291
Mol Microbiol. 2014 Sep;93(5):883-96
pubmed: 24995493
Sci Rep. 2018 Oct 8;8(1):14961
pubmed: 30297723
Can J Infect Dis. 1998 Jul;9(4):215-28
pubmed: 22346545
Nature. 2014 Sep 18;513(7518):418-21
pubmed: 25043002
Antimicrob Agents Chemother. 1991 Sep;35(9):1785-90
pubmed: 1952849
Antimicrob Agents Chemother. 2014;58(4):1956-62
pubmed: 24419348
Antimicrob Agents Chemother. 1995 Apr;39(4):812-8
pubmed: 7785976
Adv Exp Med Biol. 2015;831:1-9
pubmed: 25384659
Cell. 2013 Feb 28;152(5):997-1007
pubmed: 23452849
J Bacteriol. 2013 Jun;195(11):2452-62
pubmed: 23543719

Auteurs

Trevor Cross (T)

Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA.
Department of Microbiology, Cornell University, Ithaca, New York, USA.

Brett Ransegnola (B)

Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA.
Department of Microbiology, Cornell University, Ithaca, New York, USA.

Jung-Ho Shin (JH)

Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA.
Department of Microbiology, Cornell University, Ithaca, New York, USA.

Anna Weaver (A)

Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA.
Department of Microbiology, Cornell University, Ithaca, New York, USA.

Kathy Fauntleroy (K)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.

Michael S VanNieuwenhze (MS)

Department of Molecular and Cellular Biochemistry, Indiana University, Bloomington, Indiana, USA.
Department of Biology, Indiana University, Bloomington, Indiana, USA.

Lars F Westblade (LF)

Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA law9067@med.cornell.edu tdoerr@cornell.edu.
Division of Infectious Diseases, Department of Medicine, Weill Cornell Medicine, New York, New York, USA.

Tobias Dörr (T)

Weill Institute for Cell and Molecular Biology, Cornell University, Ithaca, New York, USA law9067@med.cornell.edu tdoerr@cornell.edu.
Department of Microbiology, Cornell University, Ithaca, New York, USA.
Cornell Institute of Host-Microbe Interactions and Disease, Cornell University, Ithaca, New York, USA.
ORCID: 0000-0003-3283-9161

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male

Management of the infected total elbow arthroplasty.

Joaquin Sanchez-Sotelo
1.00
Humans Arthroplasty, Replacement, Elbow Prosthesis-Related Infections Debridement Anti-Bacterial Agents

Mathematical modeling of vancomycin release from Poly-L-Lactic Acid-Coated implants.

Papon Thamvasupong, Kwanchanok Viravaidya-Pasuwat
1.00
Vancomycin Polyesters Anti-Bacterial Agents Models, Theoretical Drug Liberation

Menthol as an effective inhibitor of quorum sensing and biofilm formation in Candida albicans and Candida glabrata by targeting the transcriptional repressor TUP1.

Pouria Khodavandi, Maryam Miri Soogh, Fahimeh Alizadeh et al.
1.00
Biofilms Candida albicans Quorum Sensing Candida glabrata Menthol

Classifications MeSH

questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Pénicillines › Mécillinam › Spheroplast-Mediated Carbapenem Tolerance in...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Spheroplast-Mediated Carbapenem Tolerance in...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Tolérance aux médicaments › Spheroplast-Mediated Carbapenem Tolerance in...
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Enterobacter › Enterobacter aerogenes › Spheroplast-Mediated Carbapenem Tolerance in...
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Enterobacter › Enterobacter cloacae › Spheroplast-Mediated Carbapenem Tolerance in...
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Escherichia › Escherichia coli › Spheroplast-Mediated Carbapenem Tolerance in...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Spheroplast-Mediated Carbapenem Tolerance in...
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Klebsiella › Klebsiella pneumoniae › Spheroplast-Mediated Carbapenem Tolerance in...
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Carbapénèmes › Thiénamycine › Méropénème › Spheroplast-Mediated Carbapenem Tolerance in...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Spheroplast-Mediated Carbapenem Tolerance in...
questionsmedicales.fr › Stades d'organismes › Formes bactériennes atypiques › Sphéroplastes › Spheroplast-Mediated Carbapenem Tolerance in...